滚动资讯
Cell深海巨型动物利用微生物能量代谢基因以抵抗超长期饥饿Cell在量化亲和力景观上重现生发中心进化Cell异种吞噬阻断增强种间嵌合体形成FierceBiotechADA：辉瑞为berobenatide在肥胖症治疗中增添筹码，强化对Metsera收购的验证Endpoints News#ADA26：辉瑞月度注射剂对肥胖和糖尿病显示出疗效Endpoints News#ADA26: 罗氏将于今年启动petrelintide和enicepatide组合疗法的二期试验Endpoints News美议员提议限制中国；#ASCO26总结；更多资讯FierceBiotech"这个假设似乎即将得到证实"：Cullinan发布自身免疫TCEs的证据数据AmgenAmgen: A Biotech Giant's Path to Recovery and Growth - AOL.comAmgenAmgen: A Biotech Giant's Path to Recovery and Growth - The Motley FoolNovo NordiskNovo Nordisk's investigational zenagamtide shows significant A1C reductions with up to 14.6% weight loss in adults with type 2 diabetes--presented at ADA 2026 - PR Newswire

资讯库

最新 最旧 清除
@eLife
总数 570
来源 eLife
搜索 --